S-Bank Fund Management’s ResMed RMD Stock Holding History

S-Bank Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,404	Closed	-$314K	–	230
2025 Q1	$314K	Buy	+1,404	New	+$328K	0.06%	142

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

S-Bank Fund Management's RMD Position: Q2 2025 in Review

S-Bank Fund Management sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,404 shares — an estimated $314K sold.

S-Bank Fund Management first reported a position in RMD in Q1 2025 and held it in 1 quarter. The position peaked at $314K in Q1 2025. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

S-Bank Fund Management reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
S-Bank Fund Management sold 1,404 ResMed shares in Q2 2025, an estimated $314K.
S-Bank Fund Management first reported a position in ResMed in Q1 2025 and held it in 1 quarter.
S-Bank Fund Management's ResMed position peaked at $314K in Q1 2025.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on S-Bank Fund Management's 13F filing for Q2 2025, filed 29 Jul 2025.